LARS1 knockdown suppresses the biological activities of thyroid cancer cells by stimulating autophagy.
[BACKGROUND] Given the elevated prevalence of thyroid cancer in China and its status as the leading malignant endocrine tumor, identifying molecular targets for intervention is critical.
- p-value P < 0.001
APA
Jin C, Li C, et al. (2025). LARS1 knockdown suppresses the biological activities of thyroid cancer cells by stimulating autophagy.. Tissue & cell, 97, 103075. https://doi.org/10.1016/j.tice.2025.103075
MLA
Jin C, et al.. "LARS1 knockdown suppresses the biological activities of thyroid cancer cells by stimulating autophagy.." Tissue & cell, vol. 97, 2025, pp. 103075.
PMID
40815951
Abstract
[BACKGROUND] Given the elevated prevalence of thyroid cancer in China and its status as the leading malignant endocrine tumor, identifying molecular targets for intervention is critical. This study sought to define the functional significance of LARS1 in thyroid cancer pathogenesis and delineate the mechanistic pathways involved.
[MATERIALS AND METHODS] We measured LARS1 protein expression in adjacent normal and cancer tissues using immunohistochemistry. First, we knocked down LARS1 in CAL-62 and 8305 C cell lines using si-LARS1 and then inhibited autophagy using an mTOR agonist. Second, we measured cell proliferation, apoptosis rate, invasion, migration and ultrastructure using CCK-8 assay, EdU assay, flow cytometry, TUNEL staining, Transwell assay, wound healing assay and transmission electron microscopy, LC3B protein levels were evaluated by IF staining. ATG7, beclin1, P62 and TIM23 gene expression levels were measured by RT-qPCR; and LC3, ATG7, beclin1, P62 and TIM23 protein expression levels were assessed by western blot.
[RESULTS] Elevated LARS1 protein expression was consistently observed in tumor specimens relative to normal counterparts (P < 0.001). Depletion of LARS1 expression resulted in a pronounced attenuation of cellular proliferation concurrent with a substantial elevation in apoptotic rates. Furthermore, the capacities of cancer cells for invasion and migration were markedly impaired following LARS1 knockdown (P < 0.001). This manipulation also led to significant enhancements in the expression levels of both the protein and mRNA encoding ATG7 and beclin1, while diminishing the levels of TIM23 and P62. A concomitant increase in the LC3-II to LC3-I ratio was also documented. Notably, the tumor-suppressive outcomes elicited by si-LARS1 were counteracted upon administration of an mTOR agonist.
[CONCLUSION] LARS1 knockdown suppressed thyroid cancer cell abilities by regulating autophagy activation through mTOR inhibition in vitro.
[MATERIALS AND METHODS] We measured LARS1 protein expression in adjacent normal and cancer tissues using immunohistochemistry. First, we knocked down LARS1 in CAL-62 and 8305 C cell lines using si-LARS1 and then inhibited autophagy using an mTOR agonist. Second, we measured cell proliferation, apoptosis rate, invasion, migration and ultrastructure using CCK-8 assay, EdU assay, flow cytometry, TUNEL staining, Transwell assay, wound healing assay and transmission electron microscopy, LC3B protein levels were evaluated by IF staining. ATG7, beclin1, P62 and TIM23 gene expression levels were measured by RT-qPCR; and LC3, ATG7, beclin1, P62 and TIM23 protein expression levels were assessed by western blot.
[RESULTS] Elevated LARS1 protein expression was consistently observed in tumor specimens relative to normal counterparts (P < 0.001). Depletion of LARS1 expression resulted in a pronounced attenuation of cellular proliferation concurrent with a substantial elevation in apoptotic rates. Furthermore, the capacities of cancer cells for invasion and migration were markedly impaired following LARS1 knockdown (P < 0.001). This manipulation also led to significant enhancements in the expression levels of both the protein and mRNA encoding ATG7 and beclin1, while diminishing the levels of TIM23 and P62. A concomitant increase in the LC3-II to LC3-I ratio was also documented. Notably, the tumor-suppressive outcomes elicited by si-LARS1 were counteracted upon administration of an mTOR agonist.
[CONCLUSION] LARS1 knockdown suppressed thyroid cancer cell abilities by regulating autophagy activation through mTOR inhibition in vitro.
MeSH Terms
Humans; Autophagy; Thyroid Neoplasms; Cell Line, Tumor; Cell Proliferation; Cell Movement; Gene Knockdown Techniques; Apoptosis; Gene Expression Regulation, Neoplastic; Membrane Proteins; Neoplasm Invasiveness
같은 제1저자의 인용 많은 논문 (5)
- Hydroxychloroquine alleviates renal fibrosis by modulating dendritic cells glycolipid metabolism and its crosstalk with renal tubular epithelial cells.
- [Ursolic acid in Formula inhibits colorectal cancer cell growth by inducing cuproptosis].
- Transformer-based architectures in MRI brain tumor segmentation: A review.
- Engineering a cancer organoid-based platform for the early preclinical evaluation of the antitumor efficacy and safety of hydrophilic 2D metallic MoS nanosheets.
- Emerging trends and converging evidence in tumor evolution: A comprehensive review.